Navigating key news stories in pharma

Featured Stories

Featured
Reflecting a Broader Audience: CPHI Americas Event Preview
Misc.
Reflecting a Broader Audience: CPHI Americas Event Preview
Misc.

As the month of May marches on, the city of Philadelphia prepares itself to once again play host to CPHI — this year under its new guise of CPHI Americas. For 2025, the event organizers have updated the name of the show to reflect the broader audience, which incorporates Latin America and Canada in addition to North America.

Read More →
Misc.
News
Bora Adds Small-Scale Isolator Line to Baltimore Facility
Expansion
Bora Adds Small-Scale Isolator Line to Baltimore Facility
Expansion

The company has added the further sterile fill/finish capacity to the site in response to continued growth in demand for its drug product services.

Expansion
Syntegon Unveils New Aseptic Filling Line
Future Biopharma
Syntegon Unveils New Aseptic Filling Line
Future Biopharma

During Pharmatag 2025, Syntegon presented its new SynTiso aseptic filling line at Pharmatag 2025, which has been developed in collaboration with partners from the pharmaceutical industry to meet the increasing need for flexibility, contamination control, and Annex 1 compliance.

Future Biopharma
Reflecting on a Transformative Event for the Americas Pharma Market
Strategy
Reflecting on a Transformative Event for the Americas Pharma Market
Strategy

As CPHI Americas wraps up for another year, we look back at some of the highlights from the conference and exhibition hall, and provide a sneak peek of a great opportunity at CPHI Frankfurt.

Strategy

Dealmaking

Featured
CDMO Forms Strategic Collaborations for Cell-Based Therapies in Eye Disease and Solid Tumors
CDMO Forms Strategic Collaborations for Cell-Based Therapies in Eye Disease and Solid Tumors

Porton Advanced has announced separate partnerships with TongEYE and Hualong Biological, as it moves into regenerative therapies for vision loss and innovative immunotherapies for solid tumors.

Regeneron to Buy Bankrupt DNA Testing Firm
Regeneron to Buy Bankrupt DNA Testing Firm

The court supervised purchase, which is still subject to relevant conditions, will see Regeneron acquire the assets of 23andMe, except for its Lemonaid Health business.

GSK Acquires Promising Liver Disease Drug in USD 2 Billion Deal
GSK Acquires Promising Liver Disease Drug in USD 2 Billion Deal

The acquisition of efimosfermin alfa, a Phase III-ready FGF21 analog targeting steatotic liver diseases, will expand GSK’s hepatology pipeline and establish a best-in-class therapy for MASH and ALD.

Merck Enters Definitive Agreement to Acquire SpringWorks Therapeutics
Merck Enters Definitive Agreement to Acquire SpringWorks Therapeutics

Through this sizable acquisition, Merck will accelerate its growth in the rare tumor segment and boost its U.S. oncology presence.

Future Biopharma

Featured
Syntegon Unveils New Aseptic Filling Line
Syntegon Unveils New Aseptic Filling Line

During Pharmatag 2025, Syntegon presented its new SynTiso aseptic filling line at Pharmatag 2025, which has been developed in collaboration with partners from the pharmaceutical industry to meet the increasing need for flexibility, contamination control, and Annex 1 compliance.

3P Innovation Launches Generic Next-Gen DPI Filling Technology
3P Innovation Launches Generic Next-Gen DPI Filling Technology

The new DPI filling technology is an enhanced equivalent to the original filling system for the GSK Diskus DPI and will be available to manufacturers looking to produce generic products from the original Diskus and Ellipta products.

Syntegon Launches New Filling Machine for RTU Syringes
Syntegon Launches New Filling Machine for RTU Syringes

The company’s MLD Advanced uses a combination of proven technologies to enable manufacturers to quickly and efficiently meet the requirements of high outputs.

India: The Next Frontier in Global CDMO Services?
India: The Next Frontier in Global CDMO Services?

India’s pharmaceutical industry has long been synonymous with cost-effective pharmaceutical manufacturing - particularly when it comes to generic drugs. In recent years, India has been making a significant shift from low-cost generic drug production into CDMO services.

R&D

Featured
New Data Demonstrates Unique Expression Profile of RNA Platform
New Data Demonstrates Unique Expression Profile of RNA Platform

Circio presented the enhanced in vivo data for its circVec platform in viral and non-viral vectors at ASGCT 2025.

Accure Therapeutics Granted USD 1.6 Million to Advance Parkinson’s Drug Candidate
Accure Therapeutics Granted USD 1.6 Million to Advance Parkinson’s Drug Candidate

The Michael J. Fox Foundation for Parkinson’s Research and the Luxembourg National Research Fund have provided funding for two separate projects assessing Accure Therapeutics’ ACT-02 for the treatment of Parkinson’s disease.

New Analysis Strengthens Evidence of Reduced Risk of Dementia with Shingles Vaccination
New Analysis Strengthens Evidence of Reduced Risk of Dementia with Shingles Vaccination

Through analysis of historical vaccination program data, researchers have demonstrated a persistent link between the live-attenuated zoster vaccination and a lower incidence of dementia.

BioDuro Opens New Laboratory in Shanghai for Highly Potent Compound Synthesis
BioDuro Opens New Laboratory in Shanghai for Highly Potent Compound Synthesis

BioDuro, the global contract research, development and manufacturing (CRDMO) company, has opened a new state-of-the-art laboratory in Shanghai, China for the synthesis of high-potency APIs for the pharmaceutical industry.

Expansion

Featured
Bora Adds Small-Scale Isolator Line to Baltimore Facility
Bora Adds Small-Scale Isolator Line to Baltimore Facility

The company has added the further sterile fill/finish capacity to the site in response to continued growth in demand for its drug product services.

Ecolab Opens New Bioprocessing Lab in Eastern U.S.
Ecolab Opens New Bioprocessing Lab in Eastern U.S.

The new facility adds to the company’s existing infrastructure and is set to provide comprehensive technical support for bioprocessing to biopharmaceutical companies and contract manufacturers.

Amgen Further Commits to U.S. Manufacturing with Ohio Investment
Amgen Further Commits to U.S. Manufacturing with Ohio Investment

This latest investment into expanding its manufacturing capabilities reinforces the company’s commitment to the U.S. and enhances its global biomanufacturing network.

PCI Expands U.S. Fill/Finish Capabilities with Althea Acquisition
PCI Expands U.S. Fill/Finish Capabilities with Althea Acquisition

The acquisition will provide PCI with a large-scale manufacturing hub on the West Coast of the U.S., complementing its existing global facilities.

Strategy

Featured
Reflecting on a Transformative Event for the Americas Pharma Market
Reflecting on a Transformative Event for the Americas Pharma Market

As CPHI Americas wraps up for another year, we look back at some of the highlights from the conference and exhibition hall, and provide a sneak peek of a great opportunity at CPHI Frankfurt.

Novo Nordisk CEO Steps Down
Novo Nordisk CEO Steps Down

The change to the company’s leadership has been expedited as a result of the difficult market conditions and drop in share price that the company has experienced since mid-2024.

CPHI Americas 2025: Driving Innovation with BioDuro
CPHI Americas 2025: Driving Innovation with BioDuro

In this interview with The Pharma Navigator, Kevin Li from BioDuro reveals what he is looking forward to most and what the company will be showcasing at this year’s CPHI Americas event.

CPHI Americas 2025: Working End-to-End
CPHI Americas 2025: Working End-to-End

The Pharma Navigator sits down with Mara Candido from Aenova to learn more about the one-stop-shop experience, benefits of working with an end-to-end service provider, how advanced formulation strategies can aid with bioavailability/solubility issues, and the company’s focus for this year’s CPHI Americas event.  

Regulatory

Featured
Novavax’s COVID-19 Jab Gets FDA Approval
Novavax’s COVID-19 Jab Gets FDA Approval

The recombinant protein-based, non mRNA vaccine has been granted full marketing approval to prevent COVID-19 in adults aged 65 years and older and patients aged 12–64 years who are at risk of severe infection due to underlying conditions.

Verastem Gets Nod from FDA for Rare Ovarian Cancer Combo Therapy
Verastem Gets Nod from FDA for Rare Ovarian Cancer Combo Therapy

The oral combination therapy has been shown to provide a significant overall response rate in LGSOC patients with disease progression despite prior systemic treatment.

Chikungunya Vaccine Under Safety Review by EMA
Chikungunya Vaccine Under Safety Review by EMA

The European regulatory body’s safety committee has started its review of the vaccine after receiving reports of serious adverse events in elderly patients.

FDA Starts Implementing AI Rollout Across All Centers  
FDA Starts Implementing AI Rollout Across All Centers  

After a successful AI-assisted scientific pilot review, the agency has decided to implement the use of AI across all centers in an accelerated timescale.

Upcoming Events

Featured
In Vivo Cell Engineering & Gene Editing Summit 2025

This summit provides you with exclusive insights into pioneering IND enabling and clinical data, delivery technologies and effective clinical trial designs.

Chemspec Europe 2025

Chemspec Europe is a key event for the fine and speciality chemicals industry. With a highly specialised profile, the exhibition is the place to be for purchasers and agents to meet with manufacturers, suppliers and distributors of fine and speciality chemicals to source specific solutions and bespoke products.

Pre-Filled Syringes West Coast 2025

This year’s conference offers an unparalleled platform to explore cutting-edge advances in combination product technology while fostering collaboration between pharma, device developers, and regulators.

World ADC Asia Summit 2025

The 4th World ADC Asia Summit is back, offering the most comprehensive platform for Asia’s rapidly growing ADC community.